Genetic Variation in miR-27a Is Associated with Fluoropyrimidine-Associated Toxicity in Patients with Dihydropyrimidine Dehydrogenase Variants after Genotype-Guided Dose Reduction.
5-fluorouracil
DPYD
fluoropyrimidines
miR-27A
miRNA
pharmacogenomics
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 Aug 2023
27 Aug 2023
Historique:
received:
31
07
2023
revised:
21
08
2023
accepted:
24
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
Dihydropyrimidine dehydrogenase (
Identifiants
pubmed: 37686089
pii: ijms241713284
doi: 10.3390/ijms241713284
pmc: PMC10487873
pii:
doi:
Substances chimiques
Antimetabolites
0
Dihydrouracil Dehydrogenase (NADP)
EC 1.3.1.2
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : PHT-178435
Pays : Canada
Références
Pathol Res Pract. 2020 Oct;216(10):153115
pubmed: 32853952
Cancer Genet. 2016 Sep;209(9):388-394
pubmed: 27751356
Genet Mol Res. 2014 Sep 12;13(3):7420-7
pubmed: 25222241
Heliyon. 2020 Mar 12;6(3):e03565
pubmed: 32190766
Diagn Pathol. 2014 Jul 30;9:146
pubmed: 25078482
Oncotarget. 2016 Apr 19;7(16):22368-84
pubmed: 26993779
Exp Ther Med. 2023 Mar 10;25(4):179
pubmed: 37006879
Sci Rep. 2014 Aug 08;4:5993
pubmed: 25103961
Oncotarget. 2017 Apr 27;8(43):75336-75349
pubmed: 29088869
Breast Cancer Res Treat. 2012 Jul;134(2):899-901
pubmed: 22752288
J Res Med Sci. 2020 Jun 30;25:56
pubmed: 33088293
Clin Pharmacol Ther. 2018 Feb;103(2):210-216
pubmed: 29152729
Mol Cancer Ther. 2014 Mar;13(3):742-51
pubmed: 24401318
Commun Biol. 2022 Apr 4;5(1):309
pubmed: 35379867
Oncogene. 2014 Jan 9;33(2):193-202
pubmed: 23246964
Onco Targets Ther. 2015 Oct 19;8:3003-7
pubmed: 26527885
Pharmaceutics. 2019 May 01;11(5):
pubmed: 31052357
Br J Clin Pharmacol. 2015 Sep;80(3):581-8
pubmed: 25782327
World J Gastroenterol. 2012 Jun 14;18(22):2827-31
pubmed: 22719192
Lung Cancer. 2012 Jul;77(1):16-23
pubmed: 22306127
Biochem Biophys Res Commun. 2015 Mar 6;458(2):321-7
pubmed: 25656571
Eur Rev Med Pharmacol Sci. 2021 Apr;25(8):3306-3315
pubmed: 33928618
Biomedicines. 2022 Jan 12;10(1):
pubmed: 35052835
Clin Cancer Res. 2015 May 1;21(9):2038-44
pubmed: 25655103
Immunol Invest. 2017 Aug;46(6):590-602
pubmed: 28742402
Drug Metab Dispos. 2019 Aug;47(8):832-842
pubmed: 31123035
Int J Cancer. 2016 Jun 1;138(11):2752-61
pubmed: 26804235
Med Sci Monit. 2014 Nov 16;20:2318-26
pubmed: 25399405
Cells. 2023 Jan 13;12(2):
pubmed: 36672241
J Clin Lab Anal. 2016 Jul;30(4):351-5
pubmed: 26302683
PLoS One. 2013 Nov 20;8(11):e79584
pubmed: 24278149
Oncol Lett. 2017 May;13(5):3617-3623
pubmed: 28521462
EMBO Mol Med. 2017 Jun;9(6):852
pubmed: 28572088
Clin Transl Sci. 2021 Jul;14(4):1338-1348
pubmed: 33620159
J Clin Lab Anal. 2020 Mar;34(3):e23088
pubmed: 31797450
Eur J Clin Invest. 2020 Apr;50(4):e13203
pubmed: 31984489
Gene. 2020 Feb 20;728:144185
pubmed: 31838252
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Int J Biol Sci. 2020 Jul 19;16(14):2628-2647
pubmed: 32792861
Genet Mol Res. 2016 Aug 29;15(3):
pubmed: 27706637
Int J Mol Sci. 2020 Mar 03;21(5):
pubmed: 32138313
Crit Rev Oncol Hematol. 2018 Dec;132:100-110
pubmed: 30447914
J Evid Based Med. 2015 May;8(2):75-83
pubmed: 25976406